Emergency PanorOmics Wide Association for Respiratory Infections
Official title: Emergency PanorOmic Wide Association Study in Respiratory Infectious Disease (ePWAS-RID)
Run by The University of Hong Kong · NCT05336851 · Data updated 2026-11-12
This study is trying to quickly identify different respiratory infections in adults visiting the emergency room to help develop better tests and treatments for these illnesses.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | April 11, 2023 |
| Main results expected | May 1, 2028 |
| Study ends | May 1, 2028 |
| Registry record updated | May 12, 2026 |
| Trial ID | NCT05336851 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who present with suspected acute community-acquired respiratory infectious diseases.
✕Probably not a fit
Patients who are hospitalized for respiratory infections or those with chronic respiratory conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to develop an emergency PanorOmics Wide Association Study (ePWAS) to rapidly characterize known and novel infectious diseases in adults presenting to emergency departments with suspected acute respiratory infections. It involves creating a biobank for collecting clinical samples and data, which will be used for targeted research to discover new diagnostics, prognostics, and therapeutics. The study addresses the urgent need for improved preparedness and response to respiratory infectious diseases, particularly in light of the COVID-19 pandemic.
Why it matters
Potential benefit: If successful, this study could lead to faster and more accurate diagnostics and treatments for respiratory infections, ultimately improving patient outcomes.
How similar studies have gone: Other studies have shown promise in using multiomics approaches for infectious disease characterization, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients eligible for enrolment include: With reference to previous inclusion criteria are: * Adults ≥18 years of age; AND * Suspected, acute, community-acquired, respiratory, infectious disease (scaRID)\*; AND * Informed consent. Note: scaRID is defined according to ALL three criteria: 1. Community acquired (not hospitalised for \<28 days); AND 2. Acute infection (defined as symptom onset \<8 days and any ONE of reported fever or chills or aural temperature \>37.5°C or hypothermia or leucocytosis or leucopaenia or new altered mental status); AND 3. Probable respiratory infection - According to any ONE of: 1. new cough or new sputum production or 2. chest pain or 3. dyspnoea or 4. tachypnoea or 5. abnormal lung examination or 6. respiratory failure; or 7. physician's judgment (presenting with systemic or gastrointestinal symptoms). Control subjects will be drawn from two groups: * The worried well - adult patients with a National Early Warning Score (NEWS) \<3 and a temperature \<37.5°C. * Relatives or accompanying friends with no acute illness. Exclusion Criteria: * Refusal of consent; * Recent hospitalisation (\<28 days); * Enrolled in another clinical trial * Cellulitis; * Skin or orthopaedic infections; * Urinary tract infection; * Acute abdominal sepsis; * Sexual transmitted disease; * Human immunodeficiency virus (HIV) infection; * Immunocompromised/potential neutropenic fever; * Solid organ or haematopoietic stem-cell transplant within the previous 90 days; * Active graft-versus-host disease or bronchiolitis obliterans; * Severe traveller's disease requiring urgent hospitalisation and management including malaria, dengue, typhoid and other rickettsial diseases; * Stroke; * Toxidrome; * Non-organic acute psychosis.
Where it's running
-
Hong Kong University
Hong Kong, China Recruiting
Study contacts
- Principal investigator: Timothy H Rainer, MD — The University of Hong Kong
- Study coordinator: Timothy H Rainer, MD
- Email: thrainer@hku.hk
- Phone: +852 39176846
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sulbactam-Durlobactam for CRAB infections in real-world care
This real-world study tests whether sulbactam-durlobactam works and is safe for adults with carbapenem-resistant Acinetobacter baumannii infections, compared with other anti-CRAB treatments.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Understanding risk factors and biomarkers in ARDS, sepsis, and pneumonia
This study is trying to find out what causes acute respiratory distress syndrome, sepsis, and pneumonia by collecting health information and samples from hospitalized adults to help improve treatment for these conditions.
-
Validation of hematological indices in cardiac surgery patients
This study is testing if certain blood test results can help predict infections and organ problems in patients who are having heart surgery.
-
Evaluation of a multi-country medical oxygen program
This study is trying to see how medical oxygen is used in hospitals across nine countries to find ways to make it easier for patients, especially children with low oxygen levels, to get the help they need.
-
Understanding pneumonia progression in hospitalized patients with severe preexisting conditions
This study is tracking how pneumonia affects hospitalized patients with serious health issues to see if certain signs can help predict their recovery and improve their care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.